Brief: Everest Medicines As Of 5 Nov, Has Repurchased 1.6 Million Shares For About Hk$71 Million
08/11/2021 01:21
Nov 8 (Reuters) - Everest Medicines Ltd 1952.HK :
* AS OF 5 NOV, HAS EXERCISED POWERS UNDER SHARE REPURCHASE
MANDATE
& REPURCHASED 1.6 MILLION SHARES FOR ABOUT HK$71 MILLION
* DECIDED TO CONTINUE UTILIZING SHARE REPURCHASE MANDATE TO
USE UP
TO ADDITIONAL HK$100 MILLION FOR PROPOSED SHARE REPURCHASE
Further company coverage: 1952.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on Everest Medicines
See all newsBrief: Everest Medicines Says NMPA Approves Cardamyst (Etripamil) NDA For PSVT In Adults In China
Brief: Everest Medicines Enters Commercialization Collaboration With Hainan Herui Pharmaceutical
Brief: Everest Medicines Says CBC Group Purchases 712,000 Everest Medicines Shares For Hk$19.2 Million From 16 To 17 June
Australia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region